Print

EMI published a timely report about MERS in one week from its submission

During the past month, an outbreak of Middle East respiratory syndrome (MERS) in South Korea resulted in 175 confirmed cases of MERS, including 27 related deaths. One of the MERS patients in South Korea traveled to China, raising a concern that this MERS outbreak may spread to other countries in Asia. On June 2, 2015, Jiang and colleagues from Fudan University in China, who have studied the peptide- and antibody-based therapeutics for MERS since 2012 when the first MERS case was reported inSaudi Arabia, submitted a Letter to the Editor to Emerging Microbes& Infections (EMI) calling for “Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS)”. After reading the manuscript, the editor-in-chief immediately sent it out for review and asked the reviewers to return their comments as soon as possible. On June 4, 2015, the authors revised their manuscript according to the reviewers’ critiques and suggestions and submitted the revised manuscript immediately. On June 9, 2015, this article was accepted for publication in EMI.

Print

International Symposium on Infections and Vaccines

The International Symposium on Infections and Vaccines 2014(ISIV2014), a sub-forum of the International Symposium on Clinical and Translational Medicine 2014(ISCTM2014), will be held in Shanghai, China. On behalf of the Organizing Committee, we are pleased and honored to invite you to participate this big event during May 28-30, 2014.

EMI Editorial Office Address

56 Shuidian Road, Hong Kou District, Shanghai 200083, China

Tel: +86 21 56388760

Fax: +86 21 56388758

E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

Editorial Office Staff

Yin Huang, Director of Editorial Office

E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

Xiaodong Zhang, Executive Editor for Business Operation

E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.